Biotech boards are increasingly prioritizing leaders whose experience matches the company’s next milestones over résumé recognition or broad industry stature.
2
Companies seek adaptable executives who have broadened their expertise and can navigate changing markets, regulations, financing conditions, and scientific advances.
3
Chief business officers increasingly translate strategy into transactions, using market intelligence and pattern recognition to assess partnerships and deal structures.
4
Effective boards combine complementary scientific, capital markets, regulatory, operational, commercialization, and transaction expertise, while planning for future capability gaps.
5
Overreliance on existing networks can narrow candidate pools and limit diversity of perspective, making broader searches important for executive and board hiring.
